Carnexiv FDA Approval History
FDA Approved: Yes (Discontinued) (First approved October 7, 2016)
Brand name: Carnexiv
Generic name: carbamazepine
Dosage form: Injection
Company: Lundbeck Inc.
Treatment for: Seizures
Marketing Status: Discontinued
Carnexiv (carbamazepine) is an intravenous injection formulation of the antiepileptic drug carbamazepine indicated as short-term replacement therapy for oral carbamazepine when oral administration is temporarily not feasible.
Development timeline for Carnexiv
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
